NKTR icon

Nektar Therapeutics
NKTR

Overview Fund Activity

132 hedge funds and large institutions have $168M invested in Nektar Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+9
Holders Change %
+7.32%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
36
Increased
36
Reduced
34
Closed
24
Calls
$50K
Puts
$77K
Net Calls
-$27K
Net Calls Change
-$468K

Top Buyers

1
SC
Samlyn Capital
New York
$11.7M
2
BlackRock
BlackRock
New York
$18.8M
3
EAM
Eventide Asset Management
Massachusetts
$9.34M
4
Citadel Advisors
Citadel Advisors
Florida
$8.62M
5
State Street
State Street
Massachusetts
$3.71M

Top Sellers

1
MAM
Monaco Asset Management
Monaco
$2.69M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
$6.06M
3
SCM
Stonepine Capital Management
Oregon
$0
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
$430K
5
LCM
Lynx1 Capital Management
Puerto Rico
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GS
151
GTS Securities
New York
– -$10.6K -759 Closed
First Manhattan
152
First Manhattan
New York
– -$467 -33 Closed
AWM
153
Avior Wealth Management
Nebraska
– -$186 -13 Closed
CSS
154
Cubist Systematic Strategies
Connecticut
– -$37 -3 Closed
AssetMark Inc
155
AssetMark Inc
California
– -$21 -1 Closed
3 4 5 6
7